2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
White-Collar/Govt. Investigations
| White-Collar/Government Investigation — Highly Recommended |
|---|
| Cleary Gottlieb Steen & Hamilton |
| Cooley |
| Covington & Burling |
| Gibson Dunn & Crutcher |
| Hogan Lovells |
| King & Spalding |
| Morgan Lewis & Bockius |
| Ropes & Gray |
| Sidley Austin |
| WilmerHale |
| White-Collar/Government Investigation — Recommended |
|---|
| Arnold & Porter |
| Goodwin Procter |
| Latham & Watkins |
| McDermott Will & Emery |
| Schulte Roth & Zabel |
| White & Case |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Hoffinger, Adam | Non-IP Litigation & Enforcement | White-Collar/Govt. Investigations | Washington, D.C. |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Non-IP Litigation & Enforcement
Schulte Roth & Zabel
New York-based Schulte Roth & Zabel is an international, full-service law firm with additional offices in Washington, DC and London. The firm, which is highly regarded for representing several prominent hedge funds and private equity firms, has also stepped into the life sciences space in recent years. Adam Hoffinger is co-chair of the firm's white-collar and government investigations group, and has significant experience assisting life science clients. Among his recent matters, Hoffinger successfully defended a former pharmaceutical sales executive in a criminal case alleging conspiracy and violations of the federal Anti-Kickback statute. Additionally, Hoffinger also won a complete dismissal for a pharmaceutical client in a qui tam litigation involving alleged Medicare and Medicaid reimbursement violations.